CLINICAL_TRIALS
trial_result
· 2016-11-02
Clinical Trial Update: A Study of RO6807952 in Patients With Diabetes Mellitus Type 2 [Phase 1]
Summary
A Phase 1 study of RO6807952 in patients with Type 2 diabetes mellitus has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Diabetes Mellitus Type 2 | Phase 1 | Status: COMPLETED